ORCL insider sale: 19,758 shares at $300; 18,429 shares remain
Rhea-AI Filing Summary
Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 19,758 shares
Net Sell
1 txn
Insider
Levey Stuart
Role
EVP, Chief Legal Officer
Sold
19,758 shs ($5.93M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 19,758 | $300.00 | $5.93M |
Holdings After Transaction:
Common Stock — 18,429 shares (Direct)
Footnotes (1)
- F1. Sale of shares pursuant to Rule 10b5-1 Plan adopted on July 10, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ORCL disclose?
An officer sold 19,758 ORCL shares on 10/10/2025 at $300 per share under transaction code S.
Who is the reporting person in the ORCL Form 4?
An officer (EVP, Chief Legal Officer) is the reporting person, with direct ownership.
Was the Oracle insider sale under a trading plan?
Yes. It was executed under a Rule 10b5-1 Plan adopted on July 10, 2025.